C4.4A as a biomarker in pulmonary adenocarcinoma and squamous cell carcinoma
Open Access
- 1 January 2014
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Oncology
- Vol. 5 (4) , 621-632
Abstract
C4.4A as a biomarker in pulmonary adenocarcinoma and squamous cell carcinomaKeywords
This publication has 86 references indexed in Scilit:
- Ly6/uPAR-Related Protein C4.4A as a Marker of Solid Growth Pattern and Poor Prognosis in Lung AdenocarcinomaJournal of Thoracic Oncology, 2013
- Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 studyThe Lancet Oncology, 2012
- Expression of C4.4A in precursor lesions of pulmonary adenocarcinoma and squamous cell carcinomaInternational Journal of Cancer, 2011
- Non–Small Cell Lung CancerJournal of the National Comprehensive Cancer Network, 2010
- Clinicopathologic Analysis of Multiple (Five or More) Atypical Adenomatous Hyperplasias (AAHs) of the Lung: Evidence for the AAH-Adenocarcinoma SequenceJournal of Thoracic Oncology, 2010
- Lung Adenocarcinoma: Modification of the 2004 WHO Mixed Subtype to Include the Major Histologic Subtype Suggests Correlations Between Papillary and Micropapillary Adenocarcinoma Subtypes, EGFR Mutations and Gene Expression AnalysisAmerican Journal of Surgical Pathology, 2008
- Tumour cell expression of C4.4A, a structural homologue of the urokinase receptor, correlates with poor prognosis in non-small cell lung cancerLung Cancer, 2007
- The Differential Effects of Mutant p53 Alleles on Advanced Murine Lung CancerCancer Research, 2005
- Ly6 family member C4.4A binds laminins 1 and 5, associates with galectin‐3 and supports cell migrationInternational Journal of Cancer, 2005
- Early glandular neoplasia of the lungRespiratory Research, 2000